ATE303169T1 - Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften - Google Patents

Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften

Info

Publication number
ATE303169T1
ATE303169T1 AT02803343T AT02803343T ATE303169T1 AT E303169 T1 ATE303169 T1 AT E303169T1 AT 02803343 T AT02803343 T AT 02803343T AT 02803343 T AT02803343 T AT 02803343T AT E303169 T1 ATE303169 T1 AT E303169T1
Authority
AT
Austria
Prior art keywords
osteoinductive
relates
osteoconductive properties
coated device
obtainable
Prior art date
Application number
AT02803343T
Other languages
English (en)
Inventor
Ulrich Kohnert
Sylke Poehling
Klaus Hellerbrand
Peter Happersberger
Original Assignee
Scil Technology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE303169(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scil Technology Gmbh filed Critical Scil Technology Gmbh
Application granted granted Critical
Publication of ATE303169T1 publication Critical patent/ATE303169T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Apparatuses And Processes For Manufacturing Resistors (AREA)
  • Dental Preparations (AREA)
  • Prostheses (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Permanent Magnet Type Synchronous Machine (AREA)
  • Peptides Or Proteins (AREA)
AT02803343T 2001-11-19 2002-03-27 Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften ATE303169T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01127573 2001-11-19
PCT/EP2002/003463 WO2003043673A1 (en) 2001-11-19 2002-03-27 Device having osteoinductive and osteoconductive properties

Publications (1)

Publication Number Publication Date
ATE303169T1 true ATE303169T1 (de) 2005-09-15

Family

ID=8179288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02803343T ATE303169T1 (de) 2001-11-19 2002-03-27 Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften

Country Status (15)

Country Link
US (2) US8546334B2 (de)
EP (1) EP1448246B2 (de)
JP (2) JP4473576B2 (de)
CN (1) CN100425285C (de)
AT (1) ATE303169T1 (de)
AU (1) AU2002308204B9 (de)
BR (1) BR0214275A (de)
CA (1) CA2466947C (de)
CY (1) CY1105664T1 (de)
DE (1) DE60205937T3 (de)
DK (1) DK1448246T4 (de)
ES (1) ES2247423T5 (de)
PT (1) PT1448246E (de)
SI (1) SI1448246T2 (de)
WO (1) WO2003043673A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1462126A1 (de) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Verbesserte osteoinduktive Materialien
WO2005089829A2 (en) 2004-03-10 2005-09-29 Scil Technology Gmbh Coated implants, their manufacturing and use thereof
EP1604693A1 (de) 2004-06-09 2005-12-14 Scil Technology GmbH In-situ hergestelltes Gerüst, dessen Herstellungsverfahren und dessen Verwendung
WO2005120454A2 (en) * 2004-06-09 2005-12-22 Scil Technology Gmbh Composite material for use as protein carrier
EP1604694A1 (de) * 2004-06-09 2005-12-14 Scil Technology GmbH Kompositvorrichtung mit osteoinduktiven und osteokonduktiven Eigenschaften
US20060286171A1 (en) * 2005-06-17 2006-12-21 Tianhong Zhou Bone morphogenetic protein formulations
WO2007068489A2 (en) * 2005-12-14 2007-06-21 Scil Technology Gmbh A moldable biomaterial for bone regeneration
US20070299520A1 (en) * 2006-06-26 2007-12-27 Warsaw Orthopedic, Inc. Surface treatment of implantable devices
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
DE102006060958A1 (de) 2006-12-20 2008-06-26 Jennissen, Herbert P., Prof. Dr. Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
US20080221681A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Methods for Improving Fatigue Performance of Implants With Osteointegrating Coatings
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
CN101801405A (zh) 2007-08-07 2010-08-11 先进科技及再生医学有限责任公司 包含于酸性水溶液中的gdf-5的蛋白质配方
US20090061002A1 (en) * 2007-09-05 2009-03-05 Venbrocks Rudolf A Calcium phospate based delivery of growth and differentiation factors to compromised bone
DE102007051914A1 (de) * 2007-10-29 2009-05-07 Herbert Prof. Dr. Jennissen Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
JP5599778B2 (ja) * 2008-04-14 2014-10-01 デピュイ・シンセス・プロダクツ・エルエルシー 液体緩衝ｇｄｆ−５製剤
US20110059149A1 (en) * 2008-06-16 2011-03-10 Little Marisa A Process for depositing calcium phosphate therapeutic coatings with different release rates and a prosthesis coated via the process
DK2435102T3 (da) * 2009-05-28 2020-10-19 Addbio Ab Flerlagsproteinfilm, fremstillingsfremgangsmåder og lægemiddelafgivelsesindretninger samt biomedicinske implantater med anvendelse af filmene
AU2011284657B2 (en) * 2010-07-30 2013-11-14 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Drug delivery devices and growth factor formulations for accelerated wound healing
WO2012093939A1 (en) 2011-01-05 2012-07-12 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Particles comprising calcium phosphate and use thereof
CA3115298A1 (en) * 2018-10-12 2020-04-16 Theradaptive, Inc. Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
CA3119714A1 (en) 2018-11-12 2020-05-22 Nobel Biocare Services Ag Dental implant or component having a protective layer
EP3682931A1 (de) * 2019-01-21 2020-07-22 Universitätsklinikum Hamburg-Eppendorf Thorakaler katheter

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329128A1 (de) 1983-08-11 1985-02-28 Bayer Ag, 5090 Leverkusen 3-cycloalkyl-1-(1,3-dioxan-5-yl)-2-(1,2,4-triazol-1-yl)-propan-1-one und -propan-1-ole
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US5543394A (en) 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US5366875A (en) 1986-07-01 1994-11-22 Genetics Institute, Inc. Methods for producing BMP-7 proteins
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5108922A (en) 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5631142A (en) 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US5459047A (en) 1986-07-01 1995-10-17 Genetics Institute, Inc. BMP-6 proteins
US5939388A (en) 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5670336A (en) 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US5162114A (en) 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
DE68929453T2 (de) 1988-04-08 2003-11-20 Stryker Corp., Kalamazoo Osteogene Vorrichtungen
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5324819A (en) 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US4975526A (en) 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5344654A (en) 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
US5207710A (en) 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
US5258029A (en) 1988-09-29 1993-11-02 Collagen Corporation Method for improving implant fixation
US5108436A (en) 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
ATE162223T1 (de) 1989-03-28 1998-01-15 Genetics Inst Osteoinduktive zusammensetzungen
US5158934A (en) 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
WO1991005802A1 (en) 1989-10-17 1991-05-02 Creative Biomolecules, Inc. Osteogenic devices
DK27390D0 (da) 1990-02-02 1990-02-02 Troels Torp Andreassen Fremgangsmaade og apparat til administration af biologisk aktive stoffer
DK0643767T3 (da) 1990-10-18 1999-04-26 Stryker Corp Osteogene peptider
US6395883B1 (en) 1991-03-11 2002-05-28 Curis, Inc. Soluble morphogenic protein complex compositions of matter
US5650276A (en) 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
US6077823A (en) 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6399569B1 (en) 1991-03-11 2002-06-04 Curis, Inc. Morphogen treatments for limiting proliferation of epithelial cells
US5707810A (en) 1991-03-11 1998-01-13 Creative Biomolecules, Inc. Method of diagnosing renal tissue damage or disease
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
CA2363965C (en) 1991-03-11 2010-05-18 Curis, Inc. Protein-induced morphogenesis
US6211146B1 (en) 1991-03-11 2001-04-03 Curis, Inc. 60A protein-induced morphogenesis
US6090776A (en) 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US5849686A (en) 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5652337A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6723698B2 (en) 1991-03-11 2004-04-20 Curis, Inc. Methods and compositions for the treatment of motor neuron injury and neuropathy
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5972884A (en) 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
DK0575555T3 (da) 1991-03-11 2001-11-05 Curis Inc Proteininduceret morfogenese
US5652118A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US6506729B1 (en) 1991-03-11 2003-01-14 Curis, Inc. Methods and compositions for the treatment and prevention of Parkinson's disease
US5290763A (en) 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5177406A (en) 1991-04-29 1993-01-05 General Motors Corporation Active matrix vacuum fluorescent display with compensation for variable phosphor efficiency
DE4121043A1 (de) 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
EP0523926A3 (en) 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
EP1637156A1 (de) 1991-08-30 2006-03-22 Curis, Inc. Systemische Gabe osteogener Proteine zur Behandlung metabolischer Knochenkrankheiten
DE69231062T3 (de) 1991-08-30 2004-07-29 Creative Biomolecules, Inc., Hopkinton Morphogen-induzierte Modulation von entzündlichen Antworten
US6022853A (en) 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
SE469653B (sv) 1992-01-13 1993-08-16 Lucocer Ab Poroest implantat
US6120760A (en) 1992-02-12 2000-09-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Growth/differentiation factors of the TGF-β family
CA2129820C (en) 1992-02-12 2003-06-17 Helge Neidhardt Dna sequences encoding novel growth/differentiation factors
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
JPH07503869A (ja) 1992-02-14 1995-04-27 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 多相生侵食性の移植材料または担体並びにその製造および使用方法
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US5610021A (en) 1992-02-21 1997-03-11 Creative Biomolecules, Inc. Compositions and methods for identification and use of soluble complex forms of osteogenic proteins
US6071695A (en) 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
US5397235A (en) 1993-07-02 1995-03-14 Dental Marketing Specialists, Inc. Method for installation of dental implant
JP3347144B2 (ja) 1993-01-12 2002-11-20 ジェネンテク，インコーポレイテッド 骨成長を誘発させるためのＴＧＦ−β製剤
EP0690871A4 (de) 1993-01-12 1999-10-20 Univ Johns Hopkins Med Wachstums-differenzierungsfaktor-5
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US6027919A (en) 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
EP0733109B9 (de) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US5681746A (en) 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
JPH11501029A (ja) 1995-03-01 1999-01-26 クリエイティブ バイオモレキュールズ，インコーポレイテッド モルフォゲン誘導性ぞうげ質再生
US5782919A (en) * 1995-03-27 1998-07-21 Sdgi Holdings, Inc. Interbody fusion device and method for restoration of normal spinal anatomy
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US6117456A (en) 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6541037B1 (en) 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
EP2289536A1 (de) 1995-06-05 2011-03-02 Genetics Institute, LLC Verwendung von Knochenmorphogeneseproteinen zur Heilung und Reparatur von Bindegewebebefestigung
EP0883410B1 (de) * 1996-02-29 2004-08-18 Bioactive Bone Substitute OY, AB Osteogene vorrichtungen und methode zur herstellung derselben
EP0806212B1 (de) 1996-05-10 2003-04-02 IsoTis N.V. Vorrichtung zur Aufnahme und Freigabe von biologisch aktiven Substanzen
EP0806211B1 (de) 1996-05-10 2002-10-23 IsoTis N.V. Implantatwerkstoff und Verfahren zu seiner Herstellung
US6143948A (en) 1996-05-10 2000-11-07 Isotis B.V. Device for incorporation and release of biologically active agents
ATE235927T1 (de) 1996-05-10 2003-04-15 Isotis Nv Vorrichtung zur aufnahme und freigabe von biologisch aktiven substanzen
US6953594B2 (en) 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
CA2270185C (en) 1996-10-16 2009-01-06 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
DE19647853A1 (de) * 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
US20020082224A1 (en) 1997-01-14 2002-06-27 Douglas J. Jolly Non-immunogenic prodrugs and selectable markers for use in gene therapy
DK0972520T3 (da) 1997-01-30 2005-12-19 Bioph Biotech Entw Pharm Gmbh Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52
AU6267798A (en) 1997-02-07 1998-08-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US20020098222A1 (en) 1997-03-13 2002-07-25 John F. Wironen Bone paste
US20030032586A1 (en) 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
US6129928A (en) 1997-09-05 2000-10-10 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same
ATE298371T1 (de) 1997-09-24 2005-07-15 Univ California Nicht-primaten lentivirale vektoren und verpackungssysteme
EP1045921A2 (de) 1998-01-16 2000-10-25 Chiron Corporation Vom immunschwächevirus der katze (fiv) abgeleiteten gentherapievektoren
US20020048805A1 (en) 1998-01-16 2002-04-25 Julie C. Johnston Feline immunodeficiency virus gene therapy vectors
ES2291025T3 (es) 1998-05-13 2008-02-16 Genetix Pharmaceuticals Inc. Celulas lentivirales de empaquetamiento.
US6261322B1 (en) 1998-05-14 2001-07-17 Hayes Medical, Inc. Implant with composite coating
KR100298178B1 (ko) 1998-06-29 2001-08-07 박종섭 이미지센서의포토다이오드
US6328765B1 (en) 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6423544B1 (en) 1998-12-31 2002-07-23 Chiron Corporation Compositions and methods for producing recombinant virions
DE60020526T2 (de) 1999-02-04 2006-05-11 SDGI Holdings, Inc., Wilmington Osteogene pastenzusammensetzungen und ihre verwendung
CA2362049A1 (en) 1999-02-04 2000-08-10 Sdgi Holdings, Inc. Highly-mineralized osteogenic sponge compositions, and uses thereof
US6730297B1 (en) 1999-05-28 2004-05-04 Chiron Corporation Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
SE514323C2 (sv) 1999-05-31 2001-02-12 Nobel Biocare Ab Implantat samt förfarande och användning vid implantat
SE514202C2 (sv) 1999-05-31 2001-01-22 Nobel Biocare Ab På implantat till ben- eller vävnadsstruktur anordnat skikt samt sådant implantat och förfarande för applicering av skiktet
SE515695C2 (sv) * 1999-05-31 2001-09-24 Nobel Biocare Ab Implantat med beläggning av bentillväxtstimulerande substans för applicering i ben och förfarande vid sådant implantat
JP2003505206A (ja) * 1999-07-28 2003-02-12 リジェネレーション テクノロジーズ インク． 抗原性を低下させた組織（ｒａｔ）の移植片
US6696410B1 (en) * 1999-09-27 2004-02-24 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
EP1223990B1 (de) 1999-10-15 2004-07-28 Genetics Institute, LLC Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
EP1220693B1 (de) 1999-10-15 2004-12-08 Genetics Institute, LLC Zusammensetzungen zur abgabe osteogener proteine
DE19950386A1 (de) 1999-10-19 2001-05-10 Miladin Lazarov Biokompatibler Gegenstand
DE60100433T2 (de) † 2000-02-04 2004-04-15 Chienna B.V. Proteinbeschichtung
US20020022885A1 (en) * 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
EP1301214A2 (de) 2000-05-26 2003-04-16 Chiron Corporation Verfahren zur transduktion von neuronalen zellen unter verwendung von lentivirusvektoren
US6533821B1 (en) 2000-06-22 2003-03-18 Thomas Lally Bio-adhesive composition, method for adhering objects to bone
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
WO2002042482A2 (en) 2000-11-27 2002-05-30 Chiron Corporation Functional lentiviral vector from an mlv-based backbone
US20020082679A1 (en) 2000-12-22 2002-06-27 Avantec Vascular Corporation Delivery or therapeutic capable agents
CA2433657A1 (en) 2001-01-05 2002-07-11 Duke University Contrast enhancement agent for magnetic resonance imaging
US20030049328A1 (en) 2001-03-02 2003-03-13 Dalal Paresh S. Porous beta-tricalcium phosphate granules and methods for producing same
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US20020169066A1 (en) 2001-04-16 2002-11-14 Cerabio, L.L.C. Dense porous structures for use as bone substitutes
US20030039636A1 (en) 2001-05-01 2003-02-27 Genetix Pharmaceuticals, Inc. Novel self-inactivating (SIN) lentiviral vectors
ATE419810T1 (de) 2001-05-01 2009-01-15 Amedica Corp Röntgendurchlässiges knochentransplantat
SE519564C2 (sv) 2001-07-04 2003-03-11 Nobel Biocare Ab Implantat, t ex dentalt implantat, belagt med bentillväxtstimulerande medel
SE519566C2 (sv) 2001-07-04 2003-03-11 Nobel Biocare Ab Förfarande för behandling av implantat genom beläggning med kalciumfosfat och bentillväxtstimulerande medel

Also Published As

Publication number Publication date
CN1561235A (zh) 2005-01-05
ES2247423T3 (es) 2006-03-01
DE60205937T3 (de) 2016-01-21
PT1448246E (pt) 2005-11-30
HK1071315A1 (zh) 2005-07-15
JP2005509494A (ja) 2005-04-14
BR0214275A (pt) 2004-09-21
SI1448246T1 (sl) 2005-12-31
US20060088565A1 (en) 2006-04-27
EP1448246A1 (de) 2004-08-25
DE60205937D1 (de) 2005-10-06
CA2466947A1 (en) 2003-05-30
JP4473576B2 (ja) 2010-06-02
AU2002308204A1 (en) 2003-06-10
WO2003043673A1 (en) 2003-05-30
AU2002308204B9 (en) 2008-06-12
DK1448246T4 (en) 2015-12-21
CN100425285C (zh) 2008-10-15
EP1448246B1 (de) 2005-08-31
US20150080303A1 (en) 2015-03-19
ES2247423T5 (es) 2015-12-30
SI1448246T2 (sl) 2015-12-31
AU2002308204B2 (en) 2007-09-27
JP5054091B2 (ja) 2012-10-24
DE60205937T2 (de) 2006-06-14
CA2466947C (en) 2012-05-22
CY1105664T1 (el) 2010-12-22
EP1448246B2 (de) 2015-09-09
JP2010075737A (ja) 2010-04-08
DK1448246T3 (da) 2005-12-27
US8546334B2 (en) 2013-10-01

Similar Documents

Publication Publication Date Title
DE60205937T2 (de) Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften
Hing et al. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds
Xiao et al. Hollow hydroxyapatite microspheres: A novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration
Avila et al. Implant surface treatment using biomimetic agents
US20110112654A1 (en) Bone implant application
BRPI0210282B8 (pt) composições compreendendo veículos de distribuição de fosfato de cálcio para proteínas osteoindutivas, e respectivo uso
Bonazza et al. In vitro treatment with concentrated growth factors (CGF) and sodium orthosilicate positively affects cell renewal in three different human cell lines
Nyan et al. Accelerated and enhanced bone formation on novel simvastatin‐loaded porous titanium oxide surfaces
Lin et al. Long-term bone regeneration, mineralization and angiogenesis in rat calvarial defects implanted with strong porous bioactive glass (13–93) scaffolds
Pacheco et al. Tissue engineering scaffold for sequential release of vancomycin and rhBMP2 to treat bone infections
Huang et al. The synergistic effects of Chinese herb and injectable calcium silicate/β-tricalcium phosphate composite on an osteogenic accelerator in vitro
DE602004031847D1 (de) Verfahren und produkt für eine phosphosilikataufschlämmung zur verwendung in der zahnmedizin und knochenzemente in verbindung damit
Thanyaphoo et al. Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis
Jungbluth et al. Platelet‐rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini‐pigs
ES2422259T3 (es) Composiciones para la osteogénesis por distracción
Al-Hezaimi et al. Efficacy of growth factor in promoting early osseointegration
Yotsova et al. Application of platelet-rich plasma for alveolar ridge preservation. A review article
Shokri et al. Melatonin-loaded mesoporous zinc-and gallium-doped hydroxyapatite nanoparticles to control infection and bone repair
Lee et al. Bone formation and remodeling of three different dental implant surfaces with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in a rabbit model
Qiu et al. Copper‐deposited diatom‐biosilica enhanced osteogenic potential in periodontal ligament stem cells and rat cranium
IL273258B2 (en) Biomaterial comprising adipose-derived stem cells and method for producing the same
Tsai et al. Gallic acid–coated nanolayer on mineral trioxide aggregate for regulating the inflammatory and differentiation cellular response profile of human dental pulp stem cells
Ohba et al. Efficacy of platelet‐rich plasma gel and hyaluronan hydrogel as carriers of electrically polarized hydroxyapatite microgranules for accelerating bone formation
AU2003293870A1 (en) Composite materials made of calcium compounds and polysaccharides containing glucuronic acid and/or iduronic acid
Wang et al. Ascorbate–apatite composite and ascorbate–FGF-2–apatite composite layers formed on external fixation rods and their effects on cell activity in vitro

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1448246

Country of ref document: EP